A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

In Vitro Assay to Study Tumor-macrophage Interaction

7K views

DOI:

10.3791/59907

August 1st, 2019

In This Article

Summary

This article represents a useful in vitro assay to evaluate the capability of conditioned medium from tumor cells to attract macrophages.

Abstract

Tumor associated macrophages (TAMs) account for a large percentage of cells in the tumor mass for different types of cancers. Glioblastoma (GBM), a malignant brain tumor with no cure, has up to a half the tumor mass TAMs. TAMs can be pro-tumoral or anti-tumoral, depending on the activation of specific genes in the cells. Genetic mutations in the tumors, through regulating cytokine expression, can affect recruitment of TAMs to the tumor microenvironment. Here, we describe a quantitative cell-based assay to assess macrophage recruitment by the conditioned medium from the tumor cells. This assay uses the human macrophage cell line MV-4-11 to study macrophage attraction by the conditioned medium from glioblastoma, allowing for high reproducibility and low variability. Data generated with this assay can contribute to a better understanding of the interaction between the tumor and the tumor microenvironment. Similar assay can be used to assess interaction between the tumor cells and other immune cells, including T cells and natural killer (NK) cells.

Introduction

Macrophages are immune cells with high phenotypic and functional heterogeneity1. They play important roles in the host defense systems, tissue repair, development and tumor progression1. TAMs are macrophages in the microenvironment of solid tumors. Certain TAMs can promote tumor growth through inhibiting T cell-mediated cytotoxic activity, modulating the tumor microenvironment (TME), promoting angiogenesis, invasion and metastasis2,3,4,5. TAMs are among the most abundant cell types in the TME a....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Medium Preparation

  1. Preparation of the serum-free stem cell medium
    1. Thaw the 50x B27 supplement, the epidermal growth factor (EGF, 20 μg/mL in 10 mM acetic acid with 0.1% BSA), and the fibroblast growth factor (FGF, 20 μg/mL in 10 mM acetic acid with 0.1% BSA).
    2. Add 500 μL of EGF (final concentration 20 ng/mL), 500 μL of FGF (final concentration 20 ng/mL), 10 mL of 50x B27 to 500 mL of Dulbecco's Modified Eagle Medium/Nutrient Mixture F-12 (DMEM/F12) and 5 mL of 100x Penicillin/Streptomycin (Pen/Strep). Invert the bottle 4-6 times to mix, filter sterilize through a 500 mL 0.1 μm filtratio....

Access restricted. Please log in or start a trial to view this content.

Results

The results are usually showed via bar graphs (example shown in Figure 1). Samples with high 480/520 values indicate that the conditioned media has high capacity to recruit macrophages. Depending on experimental need, additional controls can be included. For example, one can use neutralizing antibodies to treat the conditioned media to abolish the macrophage chemotaxis, and perform the same assay. One can also add extra chemokines (i.e., CCL2) to the conditio.......

Access restricted. Please log in or start a trial to view this content.

Discussion

In this protocol, there are several key steps: 1) selection of the Transwell insert. For the MV-4-11 cell line, 5 μm Transwell inserts work well. However, for other cell lines such as the commonly used monocyte cell line THP-1, a different pore size might work better. 2) As different cell lines grow at different speeds, it is important to adjust the volume of the conditioned media according to cell numbers. For this purpose, cell-free media incubated under the same experimental conditions can be used to dilute the c.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

William A. Weiss is a co-founder of StemSynergy Therapeutics. Zhenyi An has nothing to disclose.

Acknowledgements

Grant Support: Z. An received support from Alex’s Lemonade Stand Foundation, American Brain Tumor Association, NIH T32CA108462 and Program for Breakthrough Biomedical Research, which is partially funded by the Sandler Foundation. W. Weiss was supported by NIH grants R01CA221969, R01NS091620, P50CA097257, U01CA217864, P30CA82103; the Samuel G. Waxman Cancer Research Foundation; and the Evelyn and Mattie Anderson Chair.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
0.1 μm filtration cupThermo fisher566-0010
0.45 μm filter unitMilliporeSLHA033SS
10 mL serological pipettesOlympus plastics12-104
15 mL sterile centrifuge tubesOlympus plastics28-103
1 mL pipette tipART molecular bioproducts2779-RI
2 mL aspirating pipetFalcon357558
24-well plateMilliporeECM507Part of ECM507, or can be purchased separately
4x lysis bufferMilliporeECM507Part of ECM507, or can be purchased separately
5 μm Transwell insertMilliporeECM507Part of ECM507, or can be purchased separately
75 cm2 flaskCorning430641U
AccutaseInnovative cell technologiesAT-104
B27Gibco12587-010
CyQuant DyeMilliporeECM507Part of ECM507, or can be purchased separately
DMEMGibco11965-092
DMEM:F12Gibco10565-018
EGFPeprotechAF-100-15
FBSGibco26140
FGFPeprotech100-18B
IMDMGibco12440-053
PBSGibco14190-144
Pen StrepGibco15140-122
Trypan blueBiorad1450021

References

  1. Liu, Y., Cao, X. The origin and function of tumor-associated macrophages. Cellular & Molecular Immunology. 12 (1), 1-4 (2015).
  2. Riabov, V., et al. Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis. Front....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Conditioned Medium AssayMacrophage RecruitmentGlioblastoma CellsMV-4-11 CellsCell Detachment SolutionTrypan Blue StainingFluorescence Plate ReaderFlow Cytometry AnalysisCyTOF Confirmation